Janatolmakan M., Jalilian M., Rezaeian S., Abdi A., Khatony A. Mortality rate and liver transplant in patients with mushroom poisoning: A systematic review & meta-analysis. Heliyon. 2023;9(1):e12759.
Rationale
Toxicology cards usually quote mortality "from…to" ranges without a sense of the true average. This study is the first attempt to assemble a single estimate across world literature.
Methods
PRISMA review of international databases to 1 March 2022; meta-analysis in CMA. 33 studies reporting mortality and liver transplantation in mushroom poisoning were included.
Results
- Mortality in individual series: 0–40% — a huge spread by species, region and ICU access.
- Pooled mortality: 2.87% (across studies reporting at least one death; excluding zero-death series gives 1.4%).
- Liver transplantation: 16 patients, 14 survived — transplantation genuinely saves lives in amatoxin injury.
- Worst prognosis: patients with established hepatic and renal involvement — i.e., late presenters.
Authors' conclusions
Mortality from mushroom poisoning is significant; organ involvement marks the highest-risk group; liver transplant is lifesaving, and early admission reduces the need for it.
Worth noting
The 2.87% figure averages highly heterogeneous series (from incidental entoloma poisoning to amatoxin outbreaks). It understates the real risk of amatoxins (10–30%) and overstates mild GI poisonings. The main conclusion echoes Enjalbert and Diaz: time decides everything — the earlier support and detoxification start, the rarer the transplant.